<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Exponent, Inc.

    Exponent, Inc.

    The Exponent name is recognized for its integrity, objectivity, independence, and ...

    The Exponent name is recognized for its integri...

    Filing Type:    PU
    Regulus Therapeutics Inc.

    Regulus Therapeutics Inc.

    Regulus Therapeutics Inc. (Nasdaq: RGLS) is a clinical stage biopharmaceutical com...

    Regulus Therapeutics Inc. (Nasdaq: RGLS) is a c...

    Filing Type:    PU
    Sensus Healthcare, Inc.

    Sensus Healthcare, Inc.

    Sensus Healthcare, Inc. (NASDAQ: SRTS; SRTSW) is a medical device company that is ...

    Sensus Healthcare, Inc. (NASDAQ: SRTS; SRTSW) i...

    Filing Type:    PU
    Celldex Therapeutics, Inc.

    Celldex Therapeutics, Inc.

    Celldex is developing targeted therapeutics to address devastating diseases for wh...

    Celldex is developing targeted therapeutics to ...

    Filing Type:    PU
    Eclipse Diagnostics Inc.

    Eclipse Diagnostics Inc.

    Eclipes Diagnostics develops CANABINOX, a handheld testing device that can accurat...

    Eclipes Diagnostics develops CANABINOX, a handh...

    Amount Raised:    $171,800.00
    Fundraising Status:    EC
    Filing Type:    CF
    Viveve Medical, Inc.

    Viveve Medical, Inc.

    Viveve, Inc., the wholly owned subsidiary of Viveve Medical, Inc., is a women's in...

    Viveve, Inc., the wholly owned subsidiary of Vi...

    Filing Type:    PU
    Nemaura Medical Inc.

    Nemaura Medical Inc.

    Nemaura Medical (NASDAQ:NMRD) is a medical technology company which has developed ...

    Nemaura Medical (NASDAQ:NMRD) is a medical tech...

    Filing Type:    PU
    Hoya Corp.

    Hoya Corp.

    Founded in 1941 in Tokyo, Japan, Hoya is a global med-tech company, and a leading ...

    Founded in 1941 in Tokyo, Japan, Hoya is a glob...

    Filing Type:    PU
    NeuroMetrix, Inc.

    NeuroMetrix, Inc.

    Founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and ...

    Founded in 1996 as a spinoff from the Harvard-M...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.